John Jui-Jen Lee

Insider Reports History

Entity
Individual
Location
1325 Boylston Street, Suite 500, Boston, MA
Signature
/s/ Jeffrey Schulz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Jui-Jen Lee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Decibel Therapeutics, Inc. Chief Development Officer Common Stock 0 $5.03 Sep 25, 2023 Direct
Decibel Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 0 Sep 25, 2023 Direct

Insider Reports Filed by John Jui-Jen Lee

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DBTX Decibel Therapeutics, Inc. Sep 25, 2023 4 $0 4 Sep 25, 2023 Chief Development Officer
DBTX Decibel Therapeutics, Inc. Jan 26, 2023 2 $0 4 Jan 30, 2023 Chief Development Officer
DBTX Decibel Therapeutics, Inc. Feb 25, 2022 1 $0 4 Feb 28, 2022 Chief Development Officer